Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias

Allan, 2011, Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors, Brain, 134, 3716, 10.1093/brain/awr273 Alvarez, 1996, Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease, Mol. Chem. Neuropathol., 29, 237, 10.1007/BF02815005 Baune, 2008, Association between IL-8 cytokine and cognitive performance in an elderly general population—the MEMO-Study, Neurobiol. Aging, 29, 937, 10.1016/j.neurobiolaging.2006.12.003 Beridze, 2011, Selected acute phase CSF factors in ischemic stroke: findings and prognostic value, BMC Neurol., 11, 41, 10.1186/1471-2377-11-41 Boraschi, 2014, Immunosenescence and vaccine failure in the elderly: strategies for improving response, Immunol. Lett., 162, 346, 10.1016/j.imlet.2014.06.006 Brosseron, 2014, Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview, Mol. Neurobiol., 50, 534, 10.1007/s12035-014-8657-1 Bruunsgaard, 1999, Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans, Clin. Exp. Immunol., 118, 235, 10.1046/j.1365-2249.1999.01045.x De Luigi, 2002, Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia, Neurobiol. Dis., 11, 308, 10.1006/nbdi.2002.0556 Deramecourt, 2012, Staging and natural history of cerebrovascular pathology in dementia, Neurology, 78, 1043, 10.1212/WNL.0b013e31824e8e7f Engelborghs, 1999, Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type, Neurochem. Int., 34, 523, 10.1016/S0197-0186(99)00031-5 Falci, 2013, Immune senescence and cancer in elderly patients: results from an exploratory study, Exp. Gerontol., 48, 1436, 10.1016/j.exger.2013.09.011 Felgenhauer, 1974, Protein size and cerebrospinal fluid composition, Klinische Wochenschrift, 52, 1158, 10.1007/BF01466734 Frei, 1989, On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases, Eur. J. Immunol., 19, 689, 10.1002/eji.1830190418 Fulop, 2010, Potential role of immunosenescence in cancer development, Ann. N. Y. Acad. Sci., 1197, 158, 10.1111/j.1749-6632.2009.05370.x Gertz, 2012, Essential role of interleukin-6 in post-stroke angiogenesis, Brain, 135, 1964, 10.1093/brain/aws075 Gimeno, 2008, Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study, Psychoneuroendocrinology, 33, 1322, 10.1016/j.psyneuen.2008.07.006 Grubeck-Loebenstein, 2009, Immunosenescence and vaccine failure in the elderly, Aging Clin. Exp. Res., 21, 201, 10.1007/BF03324904 Herrmann, 2003, Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia, J. Cereb. Blood Flow Metab., 23, 406, 10.1097/01.WCB.0000055177.50448.FA Higgins, 1994, An aligned rank transform test for interaction, Nonlinear World, 1, 201 Hoozemans, 2011, Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology, CNS Neurol. Disord. Drug Targets, 10, 57, 10.2174/187152711794488665 Hu, 2012, Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease, Neurology, 79, 897, 10.1212/WNL.0b013e318266fa70 Huberman, 1994, Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage, J. Neuroimmunol., 52, 147, 10.1016/0165-5728(94)90108-2 Huberman, 1995, IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease, J. Neurol. Sci., 130, 161, 10.1016/0022-510X(95)00016-U Ihara, 2010, Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies, Acta Neuropathol., 119, 579, 10.1007/s00401-009-0635-8 Jabbari Azad, 2014, Association between cytokine production and disease severity in Alzheimer's disease, Iran J. Allergy Asthma Immunol., 13, 433 Jang, 2008, Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1, Proc. Natl. Acad. Sci. U. S. A., 105, 7534, 10.1073/pnas.0802865105 Kalaria, 2004, Towards defining the neuropathological substrates of vascular dementia, J. Neurol. Sci., 226, 75, 10.1016/j.jns.2004.09.019 Kern, 2014, Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample, Brain Behav. Immun., 41, 55, 10.1016/j.bbi.2014.05.006 Kim, 2011, Identification of peripheral inflammatory markers between normal control and Alzheimer's disease, BMC Neurol., 11, 51, 10.1186/1471-2377-11-51 Lee, 2009, Peripheral cytokines and chemokines in Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 28, 281, 10.1159/000245156 Leung, 2013, Inflammatory proteins in plasma are associated with severity of Alzheimer's disease, PLoS One, 8, e64971, 10.1371/journal.pone.0064971 Licastro, 2000, Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?, J. Neuroimmunol., 103, 97, 10.1016/S0165-5728(99)00226-X Loddick, 1998, Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat, J. Cereb. Blood Flow Metab., 18, 176, 10.1097/00004647-199802000-00008 Montine, 2012, National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach, Acta Neuropathol., 123, 1, 10.1007/s00401-011-0910-3 Mulugeta, 2008, Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia, Dement. Geriatr. Cogn. Disord., 25, 278, 10.1159/000118633 Narasimhalu, 2015, Inflammatory markers and their association with post stroke cognitive decline, Int. J. Stroke, 10, 513, 10.1111/ijs.12001 Rafnsson, 2007, Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study, J. Am. Geriatr. Soc., 55, 700, 10.1111/j.1532-5415.2007.01158.x Richartz, 2005, Diminished production of proinflammatory cytokines in patients with Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 19, 184, 10.1159/000083497 Richartz, 2005, Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?, J. Psychiatr. Res., 39, 535, 10.1016/j.jpsychires.2004.12.005 Richartz-Salzburger, 2007, Altered lymphocyte distribution in Alzheimer's disease, J. Psychiatr. Res., 41, 174, 10.1016/j.jpsychires.2006.01.010 Ron-Harel, 2008, Age-dependent spatial memory loss can be partially restored by immune activation, Rejuvenation Res., 11, 903, 10.1089/rej.2008.0755 Schmidt, 2002, Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study, Ann. Neurol., 52, 168, 10.1002/ana.10265 Schram, 2007, Systemic markers of inflammation and cognitive decline in old age, J. Am. Geriatr. Soc., 55, 708, 10.1111/j.1532-5415.2007.01159.x Singh, 1997, Circulating cytokines in Alzheimer's disease, J. Psychiatr. Res., 31, 657, 10.1016/S0022-3956(97)00023-X Smith, 2015, Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke, Expert Opin. Investig. Drugs, 24, 623, 10.1517/13543784.2015.1020110 Sudduth, 2013, Neuroinflammatory phenotype in early Alzheimer's disease, Neurobiol. Aging, 34, 1051, 10.1016/j.neurobiolaging.2012.09.012 Sun, 2009, Interleukin-1beta is increased in the cerebrospinal fluid of patients with small infarcts, Eur. J. Neurol., 16, 858, 10.1111/j.1468-1331.2009.02609.x Suzuki, 2009, Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects, J. Cereb. Blood Flow Metab., 29, 464, 10.1038/jcbfm.2008.141 Swardfager, 2010, A meta-analysis of cytokines in Alzheimer's disease, Biol. Psychiatry, 68, 930, 10.1016/j.biopsych.2010.06.012 Tan, 2002, CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer's disease, J. Neuroimmunol., 132, 164, 10.1016/S0165-5728(02)00309-0 Vila, 2000, Proinflammatory cytokines and early neurological worsening in ischemic stroke, Stroke, 31, 2325, 10.1161/01.STR.31.10.2325 Weaver, 2002, Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging, Neurology, 59, 371, 10.1212/WNL.59.3.371 Westhoff, 2013, Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients, J. Neuroinflammation, 10, 122, 10.1186/1742-2094-10-122 Whiteley, 2009, Blood markers for the prognosis of ischemic stroke: a systematic review, Stroke, 40, e380, 10.1161/STROKEAHA.108.528752 Whiteley, 2012, The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke, Stroke, 43, 86, 10.1161/STROKEAHA.111.634089 Wright, 2006, Interleukin-6 is associated with cognitive function: the Northern Manhattan Study, J. Stroke Cerebrovasc. Dis., 15, 34, 10.1016/j.jstrokecerebrovasdis.2005.08.009 Yamada, 1995, Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia, Neurosci. Lett., 186, 219, 10.1016/0304-3940(95)11318-Q